Home/Filings/4/0001133416-23-000075
4//SEC Filing

Uihlein Richard E 4

Accession 0001133416-23-000075

CIK 0001133416other

Filed

Sep 26, 8:00 PM ET

Accepted

Sep 27, 2:03 PM ET

Size

21.1 KB

Accession

0001133416-23-000075

Insider Transaction Report

Form 4
Period: 2023-09-26
Uihlein Richard E
Director10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2023-09-26$5.00/sh+170,000$850,0009,635,495 total
  • Exercise/Conversion

    Common Stock

    2023-09-26$3.26/sh+200,000$652,00010,035,495 total
  • Exercise/Conversion

    Common Stock Purchase Warrant (right to buy)

    2023-09-26200,0000 total
    Exercise: $3.26From: 2023-03-31Exp: 2029-07-31Common Stock (200,000 underlying)
  • Exercise/Conversion

    Common Stock Purchase Warrant (right to buy)

    2023-09-261,466,2040 total
    Exercise: $5.00From: 2017-06-22Exp: 2023-12-23Common Stock (1,466,204 underlying)
  • Exercise/Conversion

    Common Stock Purchase Warrant (right to buy)

    2023-09-26170,000330,000 total
    Exercise: $5.00From: 2022-07-25Exp: 2029-07-31Common Stock (170,000 underlying)
  • Exercise/Conversion

    Common Stock Purchase Warrant (right to buy)

    2023-09-26200,0000 total
    Exercise: $3.00From: 2023-06-30Exp: 2029-07-31Common Stock (200,000 underlying)
  • Exercise/Conversion

    Common Stock

    2023-09-26$5.00/sh+1,466,204$7,331,0209,466,495 total
  • Exercise/Conversion

    Common Stock

    2023-09-26$3.00/sh+200,000$600,0009,835,495 total
  • Exercise/Conversion

    Common Stock

    2023-09-26$3.00/sh+200,000$600,00010,235,495 total
  • Exercise/Conversion

    Common Stock Purchase Warrant (right to buy)

    2023-09-26200,0000 total
    Exercise: $3.00From: 2022-12-19Exp: 2029-07-31Common Stock (200,000 underlying)
Holdings
  • Common Stock

    (indirect: By Foundation)
    27,710
Footnotes (1)
  • [F1]The reporting person is president and director of Ed Uihlein Family Foundation, a not-for-profit corporation. The reporting person has no pecuniary interest in the shares, however, he shares voting and dispositive power over the shares and, therefore, remains the beneficial owner of the shares solely for the purposes of Section 13(d) of the Securities Exchange Act of 1934.

Documents

1 file

Issuer

GALECTIN THERAPEUTICS INC

CIK 0001133416

Entity typeother

Related Parties

1
  • filerCIK 0001694903

Filing Metadata

Form type
4
Filed
Sep 26, 8:00 PM ET
Accepted
Sep 27, 2:03 PM ET
Size
21.1 KB